Private company

CAXTON CORP

Corporation registered in the United States, active since 1983. Summary from the record

Last updated Oct 21, 2026.

Overview

HeadquartersPrinceton, United States²
Legal formCorporation²
LEI549300U1TO51T4LEQK71²
StatusActive²
LEI statusIssued and current²
Registered addressC/O THE CORPORATION TRUST COMPANY, 19801 Wilmington, United States²
Registered withDivision of Corporations, Department of State, 2002138²

See how the biggest companies compare on our leaderboards

Corporate structure

CAXTON CORP sits at the top of its group. 9 entities, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

CAXTON CORP Princeton, New Jersey, United States
- Addex Therapeutics Ltd. Stake · V8
- Cardiff Oncology, Inc. Stake · San Diego, California, United States
- CTI BioPharma Stake · Seattle, Washington, United States
- Rezolute, Inc. Stake · Redwood City, California, United States
- Savara Inc Stake · Austin, Texas
- SCYNEXIS INC Stake · Jersey City, New Jersey
- Sierra Oncology, Inc. Stake · San Mateo, California
- Xeris Biopharma Holdings, Inc. Stake · Chicago, Illinois

Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); stakes of 5% or more it reported on Schedules 13D and 13G (8 companies). Each entity in the chart links to its source.

Timeline

Feb 1, 1983Founded CAXTON CORP is founded²

Filings

24 filings to the SEC since October 2021: 24 other. The latest 20:

Aug 31, 2026N-PX EDGAR
Aug 14, 202613F-HR EDGAR
May 14, 202613F-HR EDGAR
Feb 13, 202613F-HR EDGAR
Nov 14, 202513F-HR EDGAR
Aug 29, 2025N-PX EDGAR
Aug 29, 2025N-PX EDGAR
Aug 14, 202513F-HR EDGAR
May 15, 202513F-HR EDGAR
Feb 14, 202513F-HR EDGAR
Nov 14, 202413F-HR EDGAR
Sep 3, 2024N-PX EDGAR
Aug 14, 202413F-HR EDGAR
May 15, 202413F-HR EDGAR
Feb 14, 202413F-HR EDGAR
Nov 14, 202313F-HR EDGAR
Aug 14, 202313F-HR EDGAR
May 15, 202313F-HR EDGAR
Feb 14, 202313F-HR EDGAR
Nov 14, 202213F-HR EDGAR

The 24 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Stakes it holds

CAXTON CORP has told the SEC it owns more than 5% of 8 companies, latest first (Schedules 13D and 13G).

SCYNEXIS INCSC 13G/A Feb 14, 2022 to Feb 13, 2024³
Savara IncSC 13G/A Feb 14, 2022 to Feb 13, 2024⁴
Addex Therapeutics Ltd.SC 13G/A Feb 14, 2022 to Feb 14, 2023⁵
Cardiff Oncology, Inc.SC 13G/A Feb 14, 2022 to Feb 14, 2023⁶
Rezolute, Inc.SC 13G/A Feb 14, 2022 to Feb 14, 2023⁷
Xeris Biopharma Holdings, Inc.SC 13G/A Jan 5, 2022 to Feb 14, 2023⁸
CTI BioPharmaSC 13G/A Feb 14, 2022⁹
Sierra Oncology, Inc.SC 13G/A Feb 14, 2022¹⁰

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARCAXTON CORP filings on SEC EDGAR
2
GLEIFCAXTON CORP LEI record (549300U1TO51T4LEQK71)
3
SEC EDGARCAXTON CORP SC 13G/A on SCYNEXIS INC
4
SEC EDGARCAXTON CORP SC 13G/A on Savara Inc
5
SEC EDGARCAXTON CORP SC 13G/A on Addex Therapeutics Ltd.
6
SEC EDGARCAXTON CORP SC 13G/A on Cardiff Oncology, Inc.
7
SEC EDGARCAXTON CORP SC 13G/A on Rezolute, Inc.
8
SEC EDGARCAXTON CORP SC 13G/A on Xeris Biopharma Holdings, Inc.
9
SEC EDGARCAXTON CORP SC 13G/A on CTI BioPharma
10
SEC EDGARCAXTON CORP SC 13G/A on Sierra Oncology, Inc.